Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Drinks Industry News Orkney Distillery to explore feasibility of hydrogen fuel to decarbonize distilling process The HySpirits project : Orkney Distilling, Edinburgh Napier University, and the European Marine Energy Centre (EMEC) have partnered… bySrinathAugust 31, 2019
